AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and posttraumatic stress disorder. The company is based in Irvine, California.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-11-11 |
2024-09 |
-0.16 |
N/A |
N/A |
N/A |
2024-08-12 |
2024-06 |
-0.19 |
-0.16 |
0.03 |
15.79% |
2024-05-14 |
2024-03 |
-0.31 |
N/A |
N/A |
N/A |
2024-05-14 |
2024-03 |
-0.31 |
-0.28 |
0.03 |
9.68% |
Date |
Firm |
Action |
From |
To |
2023-08-17 |
HC Wainwright & Co. |
Upgrade |
|
Buy |
Date |
Name |
Relation |
Quantity |
Description |
2024-08-29 |
CARTER ERIC G |
Director |
36.02K |
Stock Award(Grant) |
2024-08-29 |
FISCHER JOST |
Director |
96.79K |
Stock Award(Grant) |
2024-08-29 |
FORTH MARC |
Chief Executive Officer |
750.55K |
Stock Award(Grant) |
2024-08-29 |
OH CHAD M.D. |
Officer |
292.55K |
Stock Award(Grant) |
2024-08-29 |
PALMISANO ROBERT J |
Director |
36.02K |
Stock Award(Grant) |
2023-07-20 |
PRIVETERRA SPONSOR, L.L.C. |
Beneficial Owner of more than 10% of a Class of Security |
0.00 |
Conversion of Exercise of derivative security |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Saba Capital Management, L.P. |
236.24K |
1.67M |
11.80% |
2023-06-29 |
Empyrean Capital Partners, LP |
200.00K |
1.42M |
9.99% |
2023-06-29 |
Fir Tree Capital Management Lp |
200.00K |
1.42M |
9.99% |
2023-06-29 |
Tenor Capital Management Co., L.p. |
200.00K |
1.42M |
9.99% |
2023-06-29 |
Periscope Capital Inc. |
150.00K |
1.06M |
7.49% |
2023-06-29 |
Sandia Investment Management LP |
117.14K |
829.32K |
5.85% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-05-30 |
Fidelity NASDAQ Composite Index Fund |
14.76K |
152.06K |
0.74% |